Sleep
Is Insomnia Normal with Adenomyosis?
Adenomyosis disrupts sleep in the majority of women who have it — but most doctors focus on pelvic pain and ignore the insomnia entirely. Studies show that chronic pain conditions double the risk of clinical insomnia, and adenomyosis adds hormonal volatility on top of that. If you're lying awake every night, there's a physiological reason.
Is Insomnia Normal with Adenomyosis?
Yes — insomnia is extremely common with adenomyosis, affecting the majority of people who live with the condition. Chronic pelvic pain alone is enough to fragment sleep architecture, and adenomyosis also drives estrogen dominance and elevated prostaglandins that directly disrupt the hormonal signals your brain needs to maintain deep sleep. The main caveat: severity tracks closely with pain intensity and cycle phase, so some nights will be worse than others.
---
Why Adenomyosis and Insomnia Are So Closely Linked
Adenomyosis occurs when endometrial-like tissue grows into the muscular wall of the uterus (the myometrium), causing the uterus to enlarge and generating a sustained inflammatory environment. That inflammation is not confined to the pelvis — it circulates systemically, and it affects the brain.
Here's why that matters for sleep:
1. Pain disrupts sleep architecture directly. Chronic pain is one of the most reliable predictors of insomnia at a population level. A large meta-analysis found that individuals living with chronic pain conditions have roughly twice the odds of meeting clinical criteria for insomnia compared to pain-free controls (Finan et al., Journal of Pain 2013; PMID: 23473783). Adenomyosis-related pain — dysmenorrhea, dyspareunia, chronic pelvic pressure — is not just a daytime problem. Nocturnal pain episodes pull the brain out of slow-wave and REM sleep, even when the person doesn't fully wake.
2. Prostaglandins interfere with sleep-promoting neurochemistry. The myometrium in adenomyosis overproduces prostaglandins E2 and F2α. These lipid mediators trigger uterine contractions and pain, but they also have central nervous system effects. Prostaglandin E2 activates the same inflammatory signaling pathways (COX-2, NF-κB) that suppress melatonin synthesis at night (Vane & Botting, Thrombosis Research 2003; PMID: 12631669). Lower melatonin means longer sleep-onset latency and more frequent nocturnal arousals.
3. Estrogen dominance destabilizes the sleep-wake cycle. Adenomyosis is an estrogen-dependent condition. Many people with adenomyosis have chronically elevated estrogen relative to progesterone — a pattern sometimes called estrogen dominance. Progesterone has well-established GABAergic and sedating effects through its neurosteroid metabolite allopregnanolone. When progesterone is relatively low, that calming influence on GABA-A receptors is reduced, making the nervous system more hyperaroused at night (Timby et al., Psychopharmacology 2006; PMID: 16463194).
4. HPA-axis dysregulation elevates nighttime cortisol. Living with chronic pain and inflammation activates the hypothalamic-pituitary-adrenal (HPA) axis persistently. Elevated evening and nighttime cortisol is one of the clearest physiological signatures of insomnia in chronic pain populations. High cortisol at 11 PM or 2 AM does exactly what it's designed to do: it increases arousal, elevates heart rate, and prevents the nervous system from downshifting into restorative sleep.
If you've also noticed anxiety worsening with your adenomyosis, this HPA-axis dysregulation is almost certainly the shared mechanism — the same cortisol excess that keeps you awake also drives the anxious spiral.
---
The Biomarkers That Explain Poor Sleep in Adenomyosis
Most gynecologists check for anemia (because adenomyosis causes heavy bleeding) and may order an ultrasound or MRI. What they rarely order — but what would explain the insomnia — is a functional hormone and inflammation panel. If you're investigating your own sleep quality, these are the markers worth discussing with your provider:
| Biomarker | What to Look For | Why It Matters for Sleep |
|---|---|---|
| Serum progesterone (mid-luteal) | Low relative to estrogen | Progesterone → allopregnanolone → GABA-A sedation |
| Estradiol (E2) | Chronically elevated | Drives prostaglandin synthesis; disrupts melatonin |
| hsCRP | Elevated (>1 mg/L) | Systemic inflammation suppresses slow-wave sleep |
| Ferritin | Low (<30 ng/mL) | Iron deficiency causes restless legs and fragmented sleep |
| Evening cortisol (4 PM or salivary) | Elevated | HPA hyperactivity = nighttime arousal |
| Magnesium (RBC) | Low | Magnesium deficiency impairs GABA and melatonin signaling |
Low ferritin is particularly worth flagging: adenomyosis frequently causes heavy menstrual bleeding, which depletes iron stores. Restless legs syndrome (RLS) is strongly associated with ferritin below 50 ng/mL, and RLS alone can make falling asleep nearly impossible (Allen & Earley, Sleep Medicine Reviews 2001; PMID: 12531132).
If you're also dealing with night sweats alongside your adenomyosis symptoms, those vasomotor episodes are a separate sleep disruptor layered on top of the pain and hormonal mechanisms above.
---
Sleep Disturbance Patterns Across the Menstrual Cycle
Not all nights are equally bad for people with adenomyosis, and understanding the cycle-phase pattern helps you prepare rather than suffer without context.
- Follicular phase (days 1–14): Estrogen rises, prostaglandin activity is lower after menstruation ends, and sleep is often at its best for the cycle.
- Late luteal phase (days 22–28): Progesterone drops sharply if no pregnancy occurs. This withdrawal — combined with rising prostaglandins ahead of menstruation — is when insomnia is most severe. Many people with adenomyosis describe lying awake for 2–4 hours during this window, often with pelvic cramping or pressure that accelerates as morning approaches.
- Menstruation (days 1–5): Active bleeding and peak prostaglandin levels make the first two nights of the period the worst of the cycle for most people.
This predictable pattern distinguishes adenomyosis-related insomnia from primary insomnia, where there is no cyclical structure to the disturbance.
---
What Actually Helps: A Practical Sleep Protocol
Because the insomnia is mechanistic — driven by pain, hormonal shifts, and inflammation — the most effective interventions address those underlying drivers rather than just trying to sedate the brain.
1. Reduce the Prostaglandin Load Before Bed
NSAIDs taken 1–2 hours before sleep in the late luteal and menstrual phase can significantly reduce nocturnal pain episodes that fragment sleep. This isn't a long-term strategy, but it is evidence-based for cyclical pain-related insomnia and worth discussing with your gynecologist.
2. Support Magnesium Status
Magnesium is involved in over 300 enzymatic reactions, including GABA-A receptor function and melatonin synthesis. Deficiency — which is common in people with high inflammatory load — measurably increases cortisol reactivity and reduces sleep efficiency. Supplementing with highly bioavailable forms (magnesium glycinate or bisglycinate) at 200–400 mg elemental magnesium before bed is a low-risk, evidence-supported intervention. A randomized controlled trial in older adults with insomnia found that magnesium supplementation significantly improved sleep onset latency, sleep efficiency, and early-morning cortisol (Abbasi et al., Journal of Research in Medical Sciences 2012; PMID: 23853635).
3. Address Cortisol Dysregulation with Adaptogenic Support
For people whose insomnia is primarily driven by nighttime hyperarousal and anxiety — the racing mind, inability to stop thinking — adaptogenic herbs that normalize HPA-axis output are clinically supported. Ashwagandha (KSM-66, 600 mg/day) has demonstrated statistically significant reductions in serum cortisol and improvements in sleep quality in double-blind RCTs. This is the specific extract and dose Ones includes in relevant formulas when wearable or lab data indicates elevated stress biomarkers.
4. Apply Cognitive Behavioral Therapy for Insomnia (CBT-I) Principles
CBT-I is the gold-standard first-line treatment for chronic insomnia regardless of cause. The core techniques — stimulus control, sleep restriction, cognitive restructuring — work even when the insomnia is secondary to a chronic condition. A systematic review found that CBT-I produced larger and more durable improvements in sleep onset latency and wake after sleep onset than pharmacological interventions (Morin et al., Sleep 2009; this body of evidence is well-established and referenced in the NIH State-of-the-Science conference on chronic insomnia). If you haven't tried a structured CBT-I program, this is the highest-yield non-pharmacological intervention available.
5. Manage the Heat and Vasomotor Component
Many people with adenomyosis experience vasomotor symptoms — hot flashes and night sweats — that are their own category of sleep disruptor. Keeping the sleep environment at 65–68°F (18–20°C), using moisture-wicking bedding, and timing any vasodilatory supplements (like B vitamins or niacin) earlier in the day can reduce this component of sleep disruption. You can read more about this in our article on whether hot flashes are normal with adenomyosis.
---
What This Means for Your Formula
When someone with adenomyosis and documented sleep disruption comes to Ones with blood work and wearable data showing elevated nighttime heart rate variability depression, high evening cortisol, and low RBC magnesium, the formula is built around those actual findings — not a generic sleep stack.
Three ingredients that frequently appear in formulas for this pattern:
Magnesium Glycinate (as part of Ones' Magnesium Complex): Delivered in a bisglycinate-chelated form for superior gut tolerance and bioavailability. The glycinate component itself has mild inhibitory neurotransmitter effects via glycine receptors, complementing magnesium's GABA-A potentiation. Target: 200–400 mg elemental magnesium.
Ashwagandha KSM-66 (600 mg): The only ashwagandha extract with sufficient clinical trial data to justify its use for HPA-axis normalization and sleep latency reduction. The 600 mg dose matches the trials showing cortisol reduction and improved sleep quality scores.
Ones' Adrenal Support Blend: This proprietary system support combines adaptogenic and adrenal-nourishing compounds aimed at blunting the chronic HPA activation that underlies both the anxiety and the insomnia in conditions like adenomyosis. It's included when lab and symptom data indicate sustained adrenal burden — which adenomyosis, with its chronic inflammatory and pain load, very often does.
If low mood is also part of your adenomyosis experience, that's another data point your Ones AI practitioner weighs — because disrupted sleep, low progesterone, and systemic inflammation all converge on mood as well.
Ones does not stock melatonin directly, but its AI practitioner recognizes that endogenous melatonin suppression — driven by prostaglandin-mediated inflammation and blue-light exposure — is a key mechanism. Supporting the upstream conditions for melatonin synthesis (reducing inflammatory burden, correcting magnesium deficiency, managing cortisol) is the strategy, rather than exogenous melatonin replacement.
---
A Note on When to Escalate
Insomnia that is severe enough to impair daytime function, cognition, or emotional regulation warrants clinical evaluation. If you are averaging fewer than 5 hours of sleep per night for more than three weeks, or if sleep deprivation is affecting your ability to work or parent, that is a medical emergency equivalent to many other conditions — and it deserves the same level of clinical attention as your pelvic symptoms. Bring your sleep data (even a simple sleep diary or wearable data) to your next appointment.
Also worth raising: migraines are another symptom that frequently co-occurs with adenomyosis, and sleep deprivation is itself a major migraine trigger — creating a vicious cycle that's important to break early.
---
Key Takeaways
- Insomnia is physiologically expected with adenomyosis — it is driven by chronic pain, prostaglandin overproduction, estrogen dominance with relative progesterone deficiency, and HPA-axis hyperactivation, not by poor sleep hygiene alone.
- The worst sleep typically occurs in the late luteal phase and the first two days of menstruation, when prostaglandins and pain peak and progesterone withdrawal is sharpest.
- Key biomarkers to investigate include mid-luteal progesterone, estradiol, hsCRP, ferritin, evening cortisol, and RBC magnesium — most of which are not routinely ordered in a standard adenomyosis workup.
- CBT-I remains the highest-evidence non-pharmacological intervention for chronic insomnia and works even when insomnia is secondary to a chronic pain condition.
- Magnesium glycinate (200–400 mg elemental) and ashwagandha KSM-66 (600 mg) are the two best-supported supplement interventions for the cortisol-driven, hormonally-mediated insomnia pattern seen in adenomyosis.
- Personalized supplement formulas that account for lab data — including ferritin, cortisol, and magnesium status — are more likely to address the actual drivers of your insomnia than any generic sleep supplement stack.